WELL Health Technologies Corp. (TSE:WEL – Get Rating) – Research analysts at Raymond James issued their Q2 2023 EPS estimates for WELL Health Technologies in a note issued to investors on Tuesday, May 23rd. Raymond James analyst R. Sarugaser forecasts that the company will post earnings per share of $0.06 for the quarter. Raymond James also issued estimates for WELL Health Technologies’ Q3 2023 earnings at $0.07 EPS, Q4 2023 earnings at $0.08 EPS, FY2023 earnings at $0.27 EPS, Q1 2024 earnings at $0.10 EPS, Q2 2024 earnings at $0.11 EPS, Q3 2024 earnings at $0.11 EPS, Q4 2024 earnings at $0.11 EPS and FY2024 earnings at $0.42 EPS.
WELL Health Technologies (TSE:WEL – Get Rating) last released its quarterly earnings results on Tuesday, March 21st. The company reported C$0.05 EPS for the quarter, beating the consensus estimate of C($0.01) by C$0.06. The firm had revenue of C$156.51 million for the quarter, compared to analyst estimates of C$153.73 million.
WELL Health Technologies Stock Performance
Further Reading
- Ralph Lauren’s Styled Dividend Is Still In Season
- Dollar Tree Falls As Theft Cuts Into Bottom Line
- Best Buy’s Comeback Is Still At Play, Earnings Call For Patience
- e.l.f. Beauty Has Giant Quarter, Shares Hit New High
- If You Can Only Pick One Stock For The Rest Of 2023, Pick Nvidia
Receive News & Ratings for WELL Health Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WELL Health Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
